Tumor-targeting oncolytic virus elicits potent immunotherapeutic vaccine responses to tumor antigens

Oncolytic viruses represent a promising therapeutic modality, but they have yet to live up to their therapeutic potential. Safety and efficacy concerns impel us to identify least toxic oncolytic agents that would generate durable and multifaceted anti-tumor immune responses to disrupt the tumors. He...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Oncoimmunology
Главные авторы: Luo, Yong, Lin, Chaolong, Zou, Yidi, Ju, Fei, Ren, Wenfeng, Lin, Yanhua, Wang, Yale, Huang, Xiaoxuan, Liu, Huiling, Yu, Zeng, Liu, Pingguo, Tan, Guowei, Yuan, Quan, Zhang, Jun, Huang, Chenghao, Xia, Ningshao
Формат: Artigo
Язык:Inglês
Опубликовано: Taylor & Francis 2020
Предметы:
Original Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7028326/
https://ncbi.nlm.nih.gov/pubmed/32117591
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2020.1726168
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы